Provided by Tiger Trade Technology Pte. Ltd.

Annexon, Inc.

5.07
-0.1100-2.12%
Post-market: 5.110.0400+0.79%19:49 EDT
Volume:1.43M
Turnover:7.31M
Market Cap:963.30M
PE:-4.50
High:5.28
Open:5.24
Low:5.02
Close:5.18
52wk High:7.18
52wk Low:2.03
Shares:190.00M
Float Shares:164.00M
Volume Ratio:0.51
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1271
EPS(LYR):-1.3445
ROE:-105.26%
ROA:-51.54%
PB:5.18
PE(LYR):-3.77

Loading ...

Annexon to Present Phase 2 Archer Data on Vision Loss Risk Factors in Geographic Atrophy at ASRS 2026

Reuters
·
Jul 15

Annexon to Present Phase 2 ARCHER Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity 15-Letter Loss in Patients with Geographic Atrophy at ASRS 2026

GlobeNewswire
·
Jul 15

Nedham biotech analysts hold an analyst/industry conference call

TIPRANKS
·
Jul 03

BRIEF-Annexon Reports Inducement Grants To New Employees Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Jun 17

Annexon grants new hires options for 705,000 shares at $4.64 each

Reuters
·
Jun 17

Annexon Stockholders Approve Directors, Compensation and Share Increase

TIPRANKS
·
Jun 13

Annexon shareholders approve charter amendment to boost authorized common shares to 500 million

Reuters
·
Jun 13

Annexon director Muneer A. Satter acquires 613,497 common shares for $3.32 million

Reuters
·
May 30

Annexon to Participate in Upcoming June Investor Conferences

GlobeNewswire
·
May 27

Annexon grants new hires options for 243,000 shares at $5.21 each

Reuters
·
May 19

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 19

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 19

MindWalk reports 10 partner-owned antibody programs in active Phase 1-3 trials

Reuters
·
May 18

MindWalk publishes Discovery-to-Clinic presentation factsheet

Reuters
·
May 18

Annexon director William H. Carson acquires 8,000 shares for $46,240

Reuters
·
May 14

Goldman Sachs Initiates Annexon at Neutral With $7 Price Target

MT Newswires Live
·
May 12

Annexon Initiated at Neutral by Goldman Sachs

Dow Jones
·
May 12

Annexon initiated with a Neutral at Goldman Sachs

TIPRANKS
·
May 12

Annexon Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Annexon Biosciences (ANNX) Gets a Buy from Bank of America Securities

TIPRANKS
·
May 10